KOD News and Press, Kodiak Sciences Inc From 10/30/23

(NewsDirect) Kodal Minerals CEO Bernard Aylward joined Proactive's Stephen Gunnion with news that the company has agreed terms with Hainan Mining to complete the funding package for the Bougouni Lithium Project in Mali. The news sent Kodal's shares 24.5% higher by the close of trade i...

Kodiak Sciences Announces Upcoming Presentations at the 56th Annual Scientific Meeting of the Retina Society PR Newswire PALO ALTO, Calif. , Oct. 11, 2023 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, de...

2023-09-26 09:51:18 ET Summary Kodiak Sciences faces growing uncertainties with tarcocimab's failure in GLEAM and GLIMMER studies, impacting its platform credibility. Financially sound with a 25-month operational runway; however, future capital allocation remains a pivotal concern...

Kodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference PR Newswire PALO ALTO, Calif. , Sept. 8, 2023 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commer...

New one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion PR Newswire Tarcocimab demonstrated strong durability, matched effica...

2023-09-01 17:32:58 ET Gainers: Diversified Healthcare  ( DHC ) +10% . Airbnb ( ABNB ) +5% . Ambrx Biopharma  ( AMAM ) +5% . NAPCO Security Technologies ( NSSC ) +5% . Premier ( PINC ) +5% . Losers: The Growth f...

(NewsDirect) Kodal Minerals PLC (AIM:KOD) chief executive Bernard Aylward speaks to Thomas Warner from Proactive after the mineral exploration and development company announced the agreement of an extension to the deadline to complete the Bougouni lithium project funding package with Hain...

2023-08-31 03:30:52 ET Summary Baker Brothers' 13F portfolio value decreased from $18.38B to $17.28B. The largest five stakes in the portfolio are Seagen, Incyte, BeiGene, ACADIA Pharmaceuticals, and Madrigal Pharmaceuticals, making up around 83% of the portfolio. Baker Brothe...

2023-08-28 17:17:30 ET Gainers: Fate Therapeutics ( NASDAQ: FATE ) +5% . Diversified Healthcare  ( DHC ) +4% . Taysha Gene Therapies ( TSHA ) +3% . Afya ( AFYA ) +3% . Iris Energy ( IREN ) +2% . Losers: Kodiak Sc...

2023-08-17 18:21:38 ET More on Kodiak Sciences Kodiak Sciences: Navigating Clinical Trials And A Competitive Landscape Kodiak cut to Neutral at UBS as lead asset dropped from trials Biggest stock movers today: Nikola, AMC Entertainment, POSCO Holdings and more ...